Shares in Novo Nordisk, maker of the obesity drug Wegovy, fell 1.9% on Tuesday following the publication of a data analysis in
Shares in Novo Nordisk, maker of the obesity drug Wegovy, fell 1.9% on Tuesday following the publication of a data analysis in